191 related articles for article (PubMed ID: 33187910)
1. Oncostatin M: A mysterious cytokine in cancers.
Masjedi A; Hajizadeh F; Beigi Dargani F; Beyzai B; Aksoun M; Hojjat-Farsangi M; Zekiy A; Jadidi-Niaragh F
Int Immunopharmacol; 2021 Jan; 90():107158. PubMed ID: 33187910
[TBL] [Abstract][Full Text] [Related]
2. The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer.
Doherty MR; Parvani JG; Tamagno I; Junk DJ; Bryson BL; Cheon HJ; Stark GR; Jackson MW
Breast Cancer Res; 2019 Apr; 21(1):54. PubMed ID: 31036052
[TBL] [Abstract][Full Text] [Related]
3. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.
Adrian-Segarra JM; Schindler N; Gajawada P; Lörchner H; Braun T; Pöling J
J Biol Chem; 2018 May; 293(18):7017-7029. PubMed ID: 29511087
[TBL] [Abstract][Full Text] [Related]
4. STAT3 Mediates the Differential Effects of Oncostatin M and TNFα on RA Synovial Fibroblast and Endothelial Cell Function.
Hanlon MM; Rakovich T; Cunningham CC; Ansboro S; Veale DJ; Fearon U; McGarry T
Front Immunol; 2019; 10():2056. PubMed ID: 31555281
[No Abstract] [Full Text] [Related]
5. Oncostatin M: Potential Implications for Malignancy and Metabolism.
Stephens JM; Elks CM
Curr Pharm Des; 2017; 23(25):3645-3657. PubMed ID: 28677505
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak/STAT3 signaling.
Lapeire L; Hendrix A; Lambein K; Van Bockstal M; Braems G; Van Den Broecke R; Limame R; Mestdagh P; Vandesompele J; Vanhove C; Maynard D; Lehuédé C; Muller C; Valet P; Gespach CP; Bracke M; Cocquyt V; Denys H; De Wever O
Cancer Res; 2014 Dec; 74(23):6806-19. PubMed ID: 25252914
[TBL] [Abstract][Full Text] [Related]
7. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
[TBL] [Abstract][Full Text] [Related]
8. STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.
Bryson BL; Junk DJ; Cipriano R; Jackson MW
Cell Cycle; 2017 Feb; 16(4):319-334. PubMed ID: 27892764
[TBL] [Abstract][Full Text] [Related]
9. The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice.
Adrian-Segarra JM; Sreenivasan K; Gajawada P; Lörchner H; Braun T; Pöling J
J Biol Chem; 2018 Dec; 293(52):20181-20199. PubMed ID: 30373773
[TBL] [Abstract][Full Text] [Related]
10. Oncostatin M-induced blood-brain barrier impairment is due to prolonged activation of STAT3 signaling in vitro.
Takata F; Dohgu S; Matsumoto J; Machida T; Sakaguchi S; Kimura I; Yamauchi A; Kataoka Y
J Cell Biochem; 2018 Nov; 119(11):9055-9063. PubMed ID: 30076740
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin M modulates fibroblast function via signal transducers and activators of transcription proteins-3.
Nagahama KY; Togo S; Holz O; Magnussen H; Liu X; Seyama K; Takahashi K; Rennard SI
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):582-91. PubMed ID: 23668543
[TBL] [Abstract][Full Text] [Related]
12. Oncostatin M suppresses metastasis of lung adenocarcinoma by inhibiting SLUG expression through coordination of STATs and PIASs signalings.
Pan CM; Wang ML; Chiou SH; Chen HY; Wu CW
Oncotarget; 2016 Sep; 7(37):60395-60406. PubMed ID: 27486982
[TBL] [Abstract][Full Text] [Related]
13. STAT3 and ERK Signaling Pathways Are Implicated in the Invasion Activity by Oncostatin M through Induction of Matrix Metalloproteinases 2 and 9.
Ko HS; Park BJ; Choi SK; Kang HK; Kim A; Kim HS; Park IY; Shin JC
Yonsei Med J; 2016 May; 57(3):761-8. PubMed ID: 26996579
[TBL] [Abstract][Full Text] [Related]
14. Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.
Walker EC; Johnson RW; Hu Y; Brennan HJ; Poulton IJ; Zhang JG; Jenkins BJ; Smyth GK; Nicola NA; Sims NA
J Biol Chem; 2016 Oct; 291(41):21703-21716. PubMed ID: 27539849
[TBL] [Abstract][Full Text] [Related]
15. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition.
Guo L; Chen C; Shi M; Wang F; Chen X; Diao D; Hu M; Yu M; Qian L; Guo N
Oncogene; 2013 Nov; 32(45):5272-82. PubMed ID: 23318420
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin M-induced upregulation of SDF-1 improves Bone marrow stromal cell migration in a rat middle cerebral artery occlusion stroke model.
Han J; Feng Z; Xie Y; Li F; Lv B; Hua T; Zhang Z; Sun C; Su D; Ouyang Q; Cai Y; Zou Y; Tang Y; Sun H; Jiang X
Exp Neurol; 2019 Mar; 313():49-59. PubMed ID: 30213507
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M binds to extracellular matrix in a bioactive conformation: implications for inflammation and metastasis.
Ryan RE; Martin B; Mellor L; Jacob RB; Tawara K; McDougal OM; Oxford JT; Jorcyk CL
Cytokine; 2015 Mar; 72(1):71-85. PubMed ID: 25622278
[TBL] [Abstract][Full Text] [Related]
18. A dual role for oncostatin M signaling in the differentiation and death of mammary epithelial cells in vivo.
Tiffen PG; Omidvar N; Marquez-Almuina N; Croston D; Watson CJ; Clarkson RW
Mol Endocrinol; 2008 Dec; 22(12):2677-88. PubMed ID: 18927239
[TBL] [Abstract][Full Text] [Related]
19. Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.
Kwofie K; Scott M; Rodrigues R; Guerette J; Radford K; Nair P; Richards CD
Respir Res; 2015 Feb; 16(1):14. PubMed ID: 25849622
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-Derived Oncostatin M Triggers Diverse Signaling Pathways during Pneumonia.
Traber KE; Dimbo EL; Shenoy AT; Symer EM; Allen E; Mizgerd JP; Quinton LJ
Infect Immun; 2021 Mar; 89(4):. PubMed ID: 33526570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
